FEBS Letters · 1995 · 18 citations · 10 references
MedicineOncologyPharmacologyCell SignalingOncogenesSignal TransductionOncogenic Signaling PathwaysRas Family OncogenesCell Type SpecificityProtein Kinase C SignalingRas Pathway ActivationRas SignalingRas Signaling ActivationRas Signaling PathwayRas-mitogen-activated Protein Kinase Signaling
We compared the influence of exogenous N-ras oncogene and treatment with PKC agonist 12-O-tetradecanoylphorbol-13-acetate (TPA) on P-glycoprotein (Pgp) function in various human, rat and dog cell lines. Two approaches were used: (a) flow cytometry analysis of Rhodamine 123 (Rh123) exclusion; and (b) sensitivity to cytotoxic action of colchicine. We have found that in Rat1 fibroblasts, rat IAR2 epithelial cells and rat McA RH 7777 (hepatoma), ras activates Pgp function, while in MDCK (dog kidney), K562 (human chronic myelogenous leukaemia) and LIM1215 (human colon carcinoma) cells it either has no effect or even acts in opposite direction. TPA-induced Pgp function shows dissimilar pattern of cell specificity. It is assumed that PKC and ras oncogene regulate mdr1 gene expression through at least partially distinct signalling pathways.
10
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
CB Lozzio, BB Lozzio · Blood · 1975 · 2.8K citations
Medicine, Hematology, Oncology +14
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
CB Lozzio, BB Lozzio · Blood · 1975 · 2.3K citations · Full text
Medicine, Hematology, Oncology +14
Modulation of Activity of the Promoter of the Human <i>MDR</i> 1 Gene by Ras and p53
Khew‐Voon Chin, Kazumitsu Ueda, Ira Pastan et al. · Science · 1992 · 731 citations